October 23, 2016 10:51 PM ET


Company Overview of Blueprint Medicines Corporation

Executive Profile

Daniel S. Lynch M.B.A.

AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 13 different industries.

See Board Relationships


Mr. Daniel S. Lynch, also known as Dan, M.B.A., has been the President and Chief Executive Officer of IVREA Pharmaceuticals Inc. since February 1, 2007. Mr. Lynch has been a Venture Partner at Third Rock Ventures, LLC since May 14, 2013. He supports the commercial and business development of existing portfolio companies and serves as a strategic advisor across the portfolio. He was an Entrepreneur-in-Residence of Third Rock Ventures, LLC from joining in May 2011 to May ...

Corporate Headquarters

38 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-374-7580
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director
Director, Member of Audit Committee and Director of US Oncology Inc
Chairman, Chairperson of Compensation Committee and Member of Audit Committee
Executive Chairman
Executive Chairman
Chairman of the Board, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee


Wesleyan University
Colgate W. Darden Graduate School of Business Administration

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$81,949
Total Calculated Compensation$81,949

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Blueprint Medicines Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.